메뉴 건너뛰기




Volumn 50, Issue 9, 2015, Pages 756-760

Nonconvulsive status epilepticus in elderly patients receiving ssris euglycemic diabetic ketoacidosis associated with canagliflozin use in a Type 1 diabetic patient duloxetine-induced galactorrhea canagliflozin-associated severe hypercalcemia and hypernatremia vemurafenib-induced fanconi syndrome

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CALCITONIN; CANAGLIFLOZIN; DIAZEPAM; DULOXETINE; GLIMEPIRIDE; GLUCOSE; INSULIN; METFORMIN; MIRTAZAPINE; PAMIDRONIC ACID; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PROLACTIN; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VEMURAFENIB;

EID: 84975745540     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj5009-756     Document Type: Article
Times cited : (2)

References (1)
  • 1
    • 84928227183 scopus 로고    scopus 로고
    • Fanconi syndrome induced by vemurafenib: A new renal adverse event
    • Denia D, Franck N, Fichel F, et al. Fanconi syndrome induced by vemurafenib: A new renal adverse event. JAMA Derm. 2015;151(4):453-454.
    • (2015) JAMA Derm. , vol.151 , Issue.4 , pp. 453-454
    • Denia, D.1    Franck, N.2    Fichel, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.